Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Edwards Lifesciences receives FDA approval for SAPIEN XT valve
Yahoo/Fly on the Wall
Monday, June 16, 2014 - 8:52pm
tags:
FDA, Sapien, Edwards Lifesciences, devices
Britain's cost agency not ready to back Gilead hepatitis C drug
Yahoo/Reuters
Monday, June 16, 2014 - 8:47pm
tags:
UK, Gilead Sciences, Sovaldi, hepatitis C
Idenix Shareholder Sues to Block $3.9 Billion Merck Deal
Bloomberg
Monday, June 16, 2014 - 8:42pm
tags:
Idenix, Merck, M&A
Big Deal By Low-Tax Medtronic Has Even Bigger Implications
Forbes
Monday, June 16, 2014 - 8:36pm
tags:
Medtronic, M&A, taxes, Covidien, devices
Biogen, AbbVie drug slows MS episodes, safety issues recur
Yahoo/Reuters
Monday, June 16, 2014 - 8:35pm
tags:
AbbVie, Biogen Idec, MS, multiple sclerosis, daclizumab
Are Investors Overestimating The Market For MannKind's Afrezza?
Seeking Alpha
Monday, June 16, 2014 - 8:32pm
tags:
MannKind, diabetes, Afrezza
Allergan Quotes Morgan Stanley to Attack Valeant, a Morgan Stanley Client
WSJ Online
Monday, June 16, 2014 - 11:30am
tags:
Allergan, Valeant Pharmaceuticals, M&A
Sanofi May Seek Other Tie-Ups to Grow in Diabetes, Zerhouni Says
Bloomberg
Monday, June 16, 2014 - 11:20am
tags:
Sanofi, diabetes
Lupin Seeks Europe Generics Acquisitions Up to $1 Billion
Bloomberg
Monday, June 16, 2014 - 11:00am
tags:
Lupin, generics, M&A
Oasmia Soars as Cancer Drug Meets Targets in Late-Stage Study
Bloomberg
Monday, June 16, 2014 - 10:52am
tags:
Oasmia, paclical, ovarian cancer
Glaxo-Tied Convergence Pain-Drug Maker Considers IPO
Bloomberg
Monday, June 16, 2014 - 10:46am
tags:
GSK, CNV1014802, trigeminal neuralgia, Convergence Pharmaceuticals
Biogen, AbbVie drug slows MS episodes, safety issues recur
Yahoo/Reuters
Monday, June 16, 2014 - 10:17am
tags:
Biogen, AbbVie, daclizumab, MS, multiple sclerosis
Ligand Promacta data should support approval, says Roth Capital
Yahoo/The Fly on the Wall
Monday, June 16, 2014 - 10:04am
tags:
Ligand Pharmaceuticals, GSK, Promacta, thrombocytopenia
Bluebird Stock Rockets On Gene Therapy Results
Forbes
Monday, June 16, 2014 - 10:02am
tags:
Bluebird Bio, beta-thalassemia
Agios Pharmaceuticals announces AG-221 orphan drug designation
Yahoo/The Fly on the Wall
Monday, June 16, 2014 - 9:58am
tags:
Agios Pharmaceuticals, AG-221, acute myelogenous leukemia, leukemia
Theralase's Cancer Technology Demonstrates Vaccine-Like Properties
Yahoo/Baystreet
Monday, June 16, 2014 - 9:55am
tags:
Theralase
The Sirens of Ziopharm
Seeking Alpha
Monday, June 16, 2014 - 7:37am
tags:
sarcoma, oncology, Ziopharm
Medtronic to buy Covidien for $42.9 billion, rebase in Ireland
Reuters
Monday, June 16, 2014 - 7:30am
tags:
M&A, devices, Ireland, Covidien, Medtronic
Better Marijuana Stock: GW Pharma vs Insys
Motley Fool
Monday, June 16, 2014 - 7:23am
tags:
Medical Marijuana, GW Pharma, Insys
Is Gene Therapy Medicine's Next Big Thing?
Motley Fool
Sunday, June 15, 2014 - 7:04pm
tags:
gene therapy, Bluebird Bio

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.